Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from India.
Pukhraj RishiPradeep T ManchegowdaHarshal P GondhaleEkta RishiKalpita DasSubramanian KrishnakumarThirumalairaj RajaJyotirmay BiswasPublished in: International ophthalmology (2021)
Intravitreal rituximab monotherapy is effective in management of vitreoretinal lymphoma in patients with isolated ocular disease.